Pursue Wealth Partners’s AbbVie ABBV Stock Holding History

Pursue Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$322K	Sell	1,281 -22	-2%	-$4.73K	0.18%	76
2026 Q1	$283K	Hold	1,303	–	–	0.17%	83
2025 Q4	$298K	Sell	1,303 -5	-0.4%	-$1.14K	0.14%	82
2025 Q3	$303K	Hold	1,308	–	–	0.17%	85
2025 Q2	$243K	Hold	1,308	–	–	0.14%	102
2025 Q1	$274K	Hold	1,308	–	–	0.17%	92
2024 Q4	$232K	Hold	1,308	–	–	0.13%	103
2024 Q3	$258K	Hold	1,308	–	–	0.14%	97
2024 Q2	$224K	Buy	+1,308	New	+$217K	0.12%	101
2022 Q3	–	Sell	-2,358	Closed	-$361K	–	110
2022 Q2	$361K	Hold	2,358	–	–	0.23%	79
2022 Q1	$409K	Hold	2,358	–	–	0.17%	95
2021 Q4	$319K	Buy	+2,358	New	+$279K	0.12%	109

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pursue Wealth Partners's ABBV Position: Q2 2026 in Review

Pursue Wealth Partners reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $4.73K and leaving 1,281 shares worth $322K. The position accounts for 0.18% of the portfolio, ranked #76.

Pursue Wealth Partners first reported a position in ABBV in Q4 2021 and has held it in 12 quarters since. The position peaked at $409K in Q1 2022. 4,222 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Pursue Wealth Partners held 1,281 shares of AbbVie worth $322K as of Q2 2026.
Pursue Wealth Partners sold 22 AbbVie shares in Q2 2026, an estimated $4.73K.
AbbVie made up 0.18% of Pursue Wealth Partners's portfolio in Q2 2026, its #76 holding.
Pursue Wealth Partners first reported a position in AbbVie in Q4 2021 and has held it in 12 quarters since.
Pursue Wealth Partners's AbbVie position peaked at $409K in Q1 2022.
4,222 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pursue Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.